Showing 1 - 3 results of 3 for search 'Anneke M. T. vanLynden‐van Nes', query time: 0.03s Refine Results
  1. 1
    Real-world Experience of Abrocitinib Treatment in Patients with Atopic Dermatitis and Hand Eczema: Up to 28-week Results from the BioDay Registry

    Real-world Experience of Abrocitinib Treatment in Patients with Atopic Dermatitis and Hand Eczema: Up to 28-week Results from the BioDay Registry by Esmé Kamphuis, Celeste M. Boesjes, Laura Loman, Marijke Kamsteeg, Inge Haeck, Anneke M.T. van Lynden-van Nes, Klaziena Politiek, Liana F. van der Gang, Marlies de Graaf, Marjolein S. de Bruin-Weller, Marie L.A. Schuttelaar

    Published 2024-02-01
    Get full text
    Article
  2. 2
    The positive effect of dupilumab on comorbid asthma in patients with atopic dermatitis

    The positive effect of dupilumab on comorbid asthma in patients with atopic dermatitis by Lotte S. Spekhorst, Marlies deGraaf, Lisa P. van derRijst, Nicolaas P. A. Zuithoff, René C. Schweizer, Marijke Kamsteeg, Inge Haeck, Anneke M. T. vanLynden‐van Nes, Paula vanLumig, Geertruida L. E. Romeijn, Marie‐Louise Schuttelaar, Marjolein S. deBruin‐Weller

    Published 2023-01-01
    Get full text
    Article
  3. 3
    Daily Practice Experience of Baricitinib Treatment for Patients with Difficult-to-Treat Atopic Dermatitis: Results from the BioDay Registry

    Daily Practice Experience of Baricitinib Treatment for Patients with Difficult-to-Treat Atopic Dermatitis: Results from the BioDay Registry by Celeste M. Boesjes, Esmé Kamphuis, Nicolaas P.A. Zuithoff, Daphne S. Bakker, Laura Loman, Lotte S. Spekhorst, Inge Haeck, Marijke Kamsteeg, Anneke M.T. van Lynden-van Nes, Floor M. Garritsen, Klaziena Politiek, Marja Oldhoff, Marlies de Graaf, Marie L.A. Schuttelaar, Marjolein S. de Bruin-Weller

    Published 2022-11-01
    Get full text
    Article

Search Tools: